Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Patrizia Ferrari"'
Autor:
Martina Arici, Shih-Che Hsu, Mara Ferrandi, Paolo Barassi, Carlotta Ronchi, Eleonora Torre, Andrea Luraghi, Gwo-Jyh Chang, Patrizia Ferrari, Giuseppe Bianchi, Francesco Peri, Antonio Zaza, Marcella Rocchetti
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background The sarcoplasmic reticulum (SR) Ca2+ ATPase (SERCA2a) depression substantially contributes to diastolic dysfunction in heart failure (HF), suggesting that SERCA2a stimulation may be a mechanism-based HF therapy. Istaroxime is a dr
Externí odkaz:
https://doaj.org/article/782d6a7de41e442dbf9d2b9799220397
Autor:
Guglielmo Imbriaco, Alessandro Monesi, Carlo Alberto Mazzoli, Lorenzo Gamberini, Patrizia Ferrari
Publikováno v:
Trends in Anaesthesia and Critical Care. 45:37-41
Autor:
Patrizia Ferrari, Guglielmo Imbriaco, Alessandro Monesi, Aimone Giugni, Carlo Alberto Mazzoli
Publikováno v:
Clinical Simulation in Nursing. 62:52-56
The COVID-19 pandemic required a global increase in intensive care unit (ICU) resources and the recruitment of a great number of nurses without any tprior critical care experience. The opportunities for traditional education and supervised clinical t
Autor:
Elena Bigi, Guglielmo Imbriaco, Aimone Giugni, Maurizio Menarini, Patrizia Ferrari, Alessandro Monesi
Publikováno v:
Air Medical Journal. 40:264-268
Objective Simulation-based training has a significant effect in enhancing professionals’ skills in the helicopter emergency medical service (HEMS) setting and is reported to be more effective than other learning strategies. The main objective of th
Autor:
Gaspare Mostacciuolo, Claudio Bussadori, Shih-Che Hsu, E. Boz, Claudia Altomare, Martina Arici, Gwo-Jyh Chang, Marcella Rocchetti, Giuseppe Bianchi, Alessandra Maria Lodrini, Emanuela Sala, Paolo Barassi, Mara Ferrandi, Sara Vagni, Patrizia Ferrari, Eleonora Torre
Publikováno v:
Cardiovascular Research. 118:1020-1032
Aims Diabetic cardiomyopathy is a multifactorial disease characterized by an early onset of diastolic dysfunction (DD) that precedes the development of systolic impairment. Mechanisms that can restore cardiac relaxation improving intracellular Ca2+ d
Autor:
Paolo Barassi, SC Hsu, Mara Ferrandi, Marcella Rocchetti, Giuseppe Bianchi, Antonio Zaza, Gwo-Jyh Chang, Francesco Peri, Martina Arici, Carlotta Ronchi, Luraghi A, Patrizia Ferrari, Eleonora Torre
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 384(1)
BackgroundHeart failure (HF) therapeutic toolkit would strongly benefit from the availability of ino-lusitropic agents with a favorable pharmacodynamics and safety profile. Istaroxime is a promising agent, which combines Na+/K+ pump inhibition with S
Autor:
Andrea Luraghi, Mara Ferrandi, Paolo Barassi, Martina Arici, Shih-Che Hsu, Eleonora Torre, Carlotta Ronchi, Alessio Romerio, Gwo-Jyh Chang, Patrizia Ferrari, Giuseppe Bianchi, Antonio Zaza, Marcella Rocchetti, Francesco Peri
Publikováno v:
Journal of medicinal chemistry. 65(10)
The stimulation of sarcoplasmic reticulum calcium ATPase SERCA2a emerged as a novel therapeutic strategy to efficiently improve overall cardiac function in heart failure (HF) with reduced arrhythmogenic risk. Istaroxime is a clinical-phase IIb compou
Publikováno v:
Nursing
In Europe, the novel coronavirus outbreak started in the northern regions of Italy at the end of February 2020. Initially, resources were insufficient to deal with the abrupt influx of critically ill patients requiring respiratory support. This artic
Autor:
Mara Ferrandi, Daniele Cusi, Tzung-Dau Wang, Patrizia Ferrari, Roberto Bigazzi, Jan A. Staessen, Lit Fui Lau, Kang Ling Wang, Chern En Chiang, Giuseppe A. Scioli, Giuseppe Bianchi, Nicola Glorioso, Li Xiaoyi, Chiara Lanzani, Silvio Cavuto, Paolo Manunta, Lorena Citterio
Publikováno v:
The Pharmacogenomics Journal
We compared a standard antihypertensive losartan treatment with a pharmacogenomics-guided rostafuroxin treatment in never-treated Caucasian and Chinese patients with primary hypertension. Rostafuroxin is a digitoxigenin derivative that selectively di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc25333df3ddbc5bf4c703ee494ece4d
Autor:
Daniele Cusi, Patrizia Ferrari, Paolo Manunta, Lorena Citterio, Mara Ferrandi, Kang-Ling Wang, Chern-En Chiang, Chiara Lanzani, Giuseppe Bianchi
Publikováno v:
Hypertension. 76
Primary hypertension contributes to more than 50% of all the worldwide cardiovascular deaths. Current antihypertensive therapy is still targeting the physiological mechanisms regulating blood pressure, but not the “causal” ones. So far, genetic s